According to a new report by Deloitte, blockchain may be the key to accelerating clinical research. Large volumes of high-quality patient data are essential for healthcare researchers to make new discoveries, but the industry is experiencing challenges when attempting to collect and leverage big data. Blockchain could provide a solution to these issues, due to its potential to streamline data sharing and enhance interoperability. (HEALTH IT ANALYTICS)
Data quality issues delay drug development
Pharmaceutical companies are concerned about their ability to bring more drugs to market faster due to clinical data challenges. 81% cited data governance issues as their biggest challenge in meeting regulatory compliance. Data governance is an important concern because clinical data quality issues can hinder a trial’s completion.